Abiopharma

BIOADAPTIVES, INC. (BDPT)

Symbol	BDPT
Name	BIOADAPTIVES, INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	89128 United States NV 2620 Regatta Drive Suite 102
Telephone	(702) 659-8829
Fax	—
Email	—
Website	http://www.bioadaptives.com
Incorporation	US
Incorporated On	2013
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	Pubco Reporting Services Inc;Boladale Lawal & Co (Chartered Accountants);
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001575142
Description	BioAdaptives Inc. is a cutting-edge research and development company focused on pioneering nutraceutical solutions for significant health challenges in humans and animals. Unlike competitors producing generic products, BioAdaptives leverages advanced scientific research to create innovative, proprietary formulations using safe, natural extracts from plants, algae, fungi, and cyanobacteria. Our flagship products include nutraceuticals that enhance the body’s natural stem cell production for cellular repair and regeneration, nootropics that deliver immediate cognitive enhancement with sustained long-term benefits, and natural weight-loss solutions that stimulate peptide secretion for safe and effective results. With a commitment to innovation and quality, BioAdaptives is positioned to capture growing demand in the global nutraceutical market, delivering transformative health solutions backed by science. Additional info from OTC: BioAdaptives Inc. is a cutting-edge research and development company focused on pioneering nutraceutical solutions for significant health challenges in humans and animals. Unlike competitors producing generic products, BioAdaptives leverages advanced scientific research to create innovative, proprietary formulations using safe, natural extracts from plants, algae, fungi, and cyanobacteria. Our flagship products include nutraceuticals that enhance the body’s natural stem cell production for cellular repair and regeneration, nootropics that deliver immediate cognitive enhancement with sustained long-term benefits, and natural weight-loss solutions that stimulate peptide secretion for safe and effective results. With a commitment to innovation and quality, BioAdaptives is positioned to capture growing demand in the global nutraceutical market, delivering transformative health solutions backed by science.

2026-03-03 21:05

FRISSORA MARK P 🟢 acquired 257.8K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Mar 01, 2026 | Filing ID: 000388

2026-02-03 21:06

FRISSORA MARK P 🟢 acquired 256.5K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Feb 01, 2026 | Filing ID: 000209

2026-01-05 21:45

FRISSORA MARK P 🟢 acquired 228.6K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Jan 01, 2026 | Filing ID: 000020

2025-12-04 00:04

Director FRISSORA MARK P 🟢 acquired 202.5K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Dec 01, 2025 | Filing ID: 001712

2025-11-04 21:30

Director FRISSORA MARK P 🟢 acquired 138.2K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Nov 01, 2025 | Filing ID: 001528

2025-10-06 20:05

Director FRISSORA MARK P 🟢 acquired 151.7K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Oct 01, 2025 | Filing ID: 001409

2025-09-03 21:14

Director FRISSORA MARK P 🟢 acquired 150.6K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Sep 01, 2025 | Filing ID: 001252

2025-08-14 00:00

(76% Positive) BioAdaptives Inc. (BDPT) Reports Net Loss for 2025-06-30

2025-08-05 21:28

Director FRISSORA MARK P 🟢 acquired 130.7K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Aug 01, 2025 | Filing ID: 001159

2025-07-03 21:09

Director FRISSORA MARK P 🟢 acquired 84.7K shares (1 derivative) of BIOADAPTIVES, INC. (BDPT) Transaction Date: Jul 01, 2025 | Filing ID: 000978